P. Mackin

发表

Rapid cycling bipolar disorder: historical overview and focus on emerging treatments.

A. Young, P. Mackin, 2004, Bipolar disorders.

Executive and visuospatial sketchpad resources in euthymic bipolar disorder: Implications for visuospatial working memory architecture

A. Young, J. M. Thompson, J. Gray, 2006, Memory.

Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin‐dependent diabetes mellitus

D. Dunger, S. Gough, T. Chowdhury, 1997, Diabetic medicine : a journal of the British Diabetic Association.

Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM

J. Todd, D. Dunger, S. Gough, 1996, Diabetologia.

Significance of microalbuminuria in long-duration type 1 diabetes.

J. M. Macleod, J. New, S. Marshall, 2003, Diabetes care.

Antiglucocorticoid treatments for mood disorders.

A. Young, I. Ferrier, P. Gallagher, 2015, The Cochrane database of systematic reviews.

Schizophrenia and increased risk of cardiovascular disease.

P. Mackin, H. McAllister-Williams, 2006, American heart journal.

Prognosis in obesity: Obesity in severe mental illness poses particular problems

A. Young, P. Mackin, 2005, BMJ : British Medical Journal.

Antiglucocorticoid treatments in mood disorders: efficacy and safety

J. Geddes, A. Young, P. Gallagher, 2005 .

A four-year naturalistic prospective study of cardiometabolic disease in antipsychotic-treated patients

P. Mackin, P. Gallagher, T. Waton, 2012, European Psychiatry.

The executivevisuospatial sketchpad interface in euthymic bipolar disorder: implications for visuospatial working memory architecture

A. Young, I. Ferrier, J. M. Thompson, 2003 .

Frontotemporal dementia: remembering images from the past

P. Mackin, R. Hamish McAllister-Williams, 2005, Neuropsychiatric disease and treatment.

Hypothalamic-pituitary-adrenal axis and bipolar disorder.

A. Young, E. Vieta, P. Mackin, 2005, The Psychiatric clinics of North America.

Changes in Brain-Derived Neurotrophic Factor Following Treatment with Mifepristone in Bipolar Disorder and Schizophrenia

A. Young, S. Watson, P. Gallagher, 2007, The Australian and New Zealand journal of psychiatry.

HPA axis function in mood disorders

S. Watson, P. Mackin, 2006 .

Renal Function in Long-Duration Type I Diabetes

J. M. Macleod, J. New, S. Marshall, 1996, Diabetes Care.

Weight gain and antipsychotics.

P. Mackin, 2005, The Journal of clinical psychiatry.

Olanzapine-induced hyperglycemic hyperosmolar nonketotic coma: a case report.

A. Young, P. Mackin, Mariposa Mccall, 2004 .

Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study

A. Young, P. Mackin, H. Watkinson, 2005, Diabetologia.

Antiglucocorticoid treatments for mood disorders (Withdrawn Paper. 2015, Art. no. CD005168)

A. Young, I. Ferrier, P. Gallagher, 2015 .

Wake-up call for British psychiatry

Klaus P. Ebmeier, N. Craddock, A. Bailey, 2008, British Journal of Psychiatry.

Physical Comorbidity in Bipolar Disorder

P. Mackin, Sylvia Ruttledge, 2007 .

Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs

P. Mackin, L. Agius, L. Hampson, 2007, Diabetologia.

Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature

A. Lloyd, A. Lloyd, P. Mackin, 2010, Journal of psychopharmacology.

Culture and assessment of manic symptoms

A. Young, P. Mackin, S. Targum, 2006, British Journal of Psychiatry.

Cardiac side effects of psychiatric drugs

P. Mackin, Paul Mackin, 2008, Human psychopharmacology.

Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia

A. Heald, J. Vora, A. Barnett, 2007, Journal of psychopharmacology.

Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes.

P. Gallagher, P. Mackin, 2005, International journal of cardiology.

21 – Bipolar disorders

A. Young, P. Mackin, 2012 .

Extended unemployment benefits

P. Mackin, 1965 .

Sleep disordered breathing in community psychiatric patients

K. Anderson, P. Mackin, D. Armstrong, 2012 .

Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community.

I. Ferrier, P. Gallagher, P. Mackin, 2007, The British journal of psychiatry : the journal of mental science.

Atypical antipsychotic drugs

P. Mackin, S. Thomas, 2011, BMJ : British Medical Journal.

Prolactin and smoking status in antipsychotic-treated patients

P. Mackin, A. Nulkar, H. Watkinson, 2011, Journal of psychopharmacology.

QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study.

A. Young, P. Mackin, 2005, The Journal of clinical psychiatry.

A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients

P. Mackin, H. Watkinson, D. Bishop, 2007, BMC psychiatry.

The Role of Cortisol and Depression: Exploring New Opportunities for Treatments

A. Young, P. Mackin, Mrcpsych, 2004 .

A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients

P. Mackin, H. Watkinson, D. Bishop, 2007, BMC psychiatry.